Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Sep 26:14:1445427.
doi: 10.3389/fonc.2024.1445427. eCollection 2024.

Case report: Tenosynovial giant cell tumor

Affiliations
Case Reports

Case report: Tenosynovial giant cell tumor

Anke Fähnrich et al. Front Oncol. .

Abstract

Tenosynovial giant cell tumor (TGCT) is a rare type of tumor that originates from the synovium of joints and tendon sheaths. It is characterized by recurring genetic abnormalities, often involving the CSF1 gene. Common symptoms include pain and swelling, which are not specific to TGCT, so MRI and a pathological biopsy are needed for an accurate diagnosis. We report the case of a 45-year-old man who experienced painful swelling in his right hip for six months. Initially, this was diagnosed as Erdheim-Chester disease. However, whole exome sequencing (WES) and RNA-Sequencing revealed a CSF1::GAPDHP64 fusion, leading to a revised diagnosis of TGCT. The patient was treated with pegylated interferon and imatinib, which resulted in stable disease after three months. Single-cell transcriptome analysis identified seven distinct cell clusters, revealing that neoplastic cells expressing CSF1 attract macrophages. Analysis of ligand-receptor interactions showed significant communication between neoplastic cells and macrophages mediated by CSF1 and CSF1R. Our findings emphasize the importance of comprehensive molecular analysis in diagnosing and treating rare malignancies like TGCT.

Keywords: CSF1 fusion transcript; RNA sequencing (RNA-seq); molecular tumor board (MTB); single cell sequencing (scRNA-seq); tenosynovial giant cell tumor (TGCT).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
MRT images of the affected femoral head in the transverse plane (A) and frontal plane (B). Tumor tissue with a predominance of infiltrating foamy macrophages, cleft-like spaces (arrows), and multinucleated giant cells (arrowheads) in hematoxylin and eosin stainings (C) and immunostaining for CD68 (D). Original magnifications 200x, bar indicates 200 µm.
Figure 2
Figure 2
scRNA-seq analysis of cellular composition of bone marrow from Tenosynovial Giant Cell Tumor patient. Single-cell suspension from tenosynovial giant cell tumor patient analyzed by scRNA-seq. (A) UMAP plot of seven distinct cell clusters. (B) Violin plots of marker gene expression for the seven distinct clusters. (C) Relative pathway enrichment. Red indicates positive, whilst blue indicates negative enrichment.

References

    1. Mastboom MJL, Verspoor FGM, Verschoor AJ, Uittenbogaard D, Nemeth B, Mastboom WJB, et al. . Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthopaedica. (2017) 88:688–94. doi: 10.1080/17453674.2017.1361126 - DOI - PMC - PubMed
    1. Cupp JS, Miller MA, Montgomery KD, Nielsen TO, O’Connell JX, Huntsman D, et al. . Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. (2007) 31:970–6. doi: 10.1097/PAS.0b013e31802b86f8 - DOI - PubMed
    1. Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, et al. . Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts. Cancer Treat Rev. (2023) 112:102491. doi: 10.1016/j.ctrv.2022.102491 - DOI - PubMed
    1. Verspoor FG, van der Geest IC, Vegt E, Veth RP, van der Graaf WT, Schreuder HW. Pigmented villonodular synovitis: current concepts about diagnosis and management. Future Oncol (London England). (2013) 9:1515–31. doi: 10.2217/fon.13.124 - DOI - PubMed
    1. Wan JM, Magarelli N, Peh WC, Guglielmi G, Shek TW. Imaging of giant cell tumour of the tendon sheath. La Radiol Med. (2010) 115:141–51. doi: 10.1007/s11547-010-0515-2 - DOI - PubMed

Publication types

LinkOut - more resources